(VVUS, LOGL, DDD, FROG) CRWENewswire
VIVUS Inc - VVUS - reported that the FDA Advisory Committee recommended Qnexa be granted marketing approval by the FDA for the treatment of obesity in adults.
23 Feb 2012
VIVUS Inc - VVUS - reported that the FDA Advisory Committee recommended Qnexa be granted marketing approval by the FDA for the treatment of obesity in adults.
23 Feb 2012
Comentários